Colette Kosik‐Gonzalez

797 total citations
18 papers, 558 citations indexed

About

Colette Kosik‐Gonzalez is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Colette Kosik‐Gonzalez has authored 18 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 5 papers in Clinical Psychology. Recurrent topics in Colette Kosik‐Gonzalez's work include Treatment of Major Depression (8 papers), Schizophrenia research and treatment (8 papers) and Bipolar Disorder and Treatment (5 papers). Colette Kosik‐Gonzalez is often cited by papers focused on Treatment of Major Depression (8 papers), Schizophrenia research and treatment (8 papers) and Bipolar Disorder and Treatment (5 papers). Colette Kosik‐Gonzalez collaborates with scholars based in United States, Canada and Belgium. Colette Kosik‐Gonzalez's co-authors include Ramy Mahmoud, Carla M. Canuso, Cynthia A. Bossie, Ibrahim Turkoz, Georges M. Gharabawi, Andrew Greenspan, Jennifer Carothers, Marcia F.T. Rupnow, Per G. Djupesland and Young Zhu and has published in prestigious journals such as Annals of Internal Medicine, American Journal of Psychiatry and Journal of Allergy and Clinical Immunology.

In The Last Decade

Colette Kosik‐Gonzalez

18 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colette Kosik‐Gonzalez United States	10	375	167	92	72	69	18	558
Doron Mazeh Israel	16	326 0.9×	89 0.5×		86 1.2×	34 0.5×	21	544
Na Jin United States	10	636 1.7×	57 0.3×	2 0.0×	169 2.3×	20 0.3×	17	738
Robin Haddad United States	7	41 0.1×	31 0.2×	14 0.2×	59 0.8×	54 0.8×	7	538
Gary J. Gala United States	9	45 0.1×	33 0.2×		63 0.9×	17 0.2×	19	351
Hallie Thomas Norway	14	505 1.3×	67 0.4×	2 0.0×	73 1.0×	50 0.7×	22	680
Irene Romera Spain	13	147 0.4×	224 1.3×		95 1.3×	56 0.8×	36	641
O.‐P. Mehtonen Finland	5	563 1.5×	210 1.3×	2 0.0×	94 1.3×	17 0.2×	7	776
T Schut Netherlands	9	137 0.4×	107 0.6×		47 0.7×	16 0.2×	21	447
Maria Teresa Cruz Lourenço Canada	12	177 0.5×	59 0.4×	3 0.0×	57 0.8×	21 0.3×	19	552
Chin-Hong Chan Taiwan	13	102 0.3×	24 0.1×		47 0.7×	40 0.6×	17	320

Countries citing papers authored by Colette Kosik‐Gonzalez

Since Specialization

Citations

This map shows the geographic impact of Colette Kosik‐Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colette Kosik‐Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colette Kosik‐Gonzalez more than expected).

Fields of papers citing papers by Colette Kosik‐Gonzalez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colette Kosik‐Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colette Kosik‐Gonzalez. The network helps show where Colette Kosik‐Gonzalez may publish in the future.

Co-authorship network of co-authors of Colette Kosik‐Gonzalez

This figure shows the co-authorship network connecting the top 25 collaborators of Colette Kosik‐Gonzalez. A scholar is included among the top collaborators of Colette Kosik‐Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colette Kosik‐Gonzalez. Colette Kosik‐Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kosik‐Gonzalez, Colette, Dong‐Jing Fu, Rosanne Lane, et al.. (2025). Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study. Journal of the American Academy of Child & Adolescent Psychiatry. 65(1). 42–55. 3 indexed citations

DelBello, Melissa P., Colette Kosik‐Gonzalez, Dong‐Jing Fu, et al.. (2023). Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Depressive Symptoms in Adolescents With MDD at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Psychoactive-Controlled Study. Journal of the American Academy of Child & Adolescent Psychiatry. 62(10). S319–S320. 2 indexed citations

Leopold, Donald A., David Elkayam, John Messina, et al.. (2018). NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis. Journal of Allergy and Clinical Immunology. 143(1). 126–134.e5. 66 indexed citations

Palmer, James N., Kraig W. Jacobson, John Messina, et al.. (2018). EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis. International Forum of Allergy & Rhinology. 8(8). 869–876. 37 indexed citations

Canuso, Carla M., Jean‐Pierre Lindenmayer, Colette Kosik‐Gonzalez, et al.. (2010). A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder. The Journal of Clinical Psychiatry. 71(5). 587–598. 55 indexed citations

Canuso, Carla M., Nina R. Schooler, Jennifer Carothers, et al.. (2010). Paliperidone Extended-Release in Schizoaffective Disorder. Journal of Clinical Psychopharmacology. 30(5). 487–495. 45 indexed citations

Canuso, Carla M., Bryan Dirks, Jennifer Carothers, et al.. (2009). Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia. American Journal of Psychiatry. 166(6). 691–701. 56 indexed citations

Canuso, Carla M., Colette Kosik‐Gonzalez, Amir H Kalali, et al.. (2008). 83 – Frequency of schizoaffective disorder diagnosis in patients with psychotic disorders using the mini-international neuropsychiatric interview. Schizophrenia Research. 98. 67–68. 1 indexed citations

Canuso, Carla M., Jennifer Carothers, Bryan Dirks, et al.. (2008). A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL COMPARING PALIPERIDONE ER AND QUETIAPINE IN PATIENTS WITH A RECENT ACUTE EXACERBATION OF SCHIZOPHRENIA. Schizophrenia Research. 102(1-3). 252–252. 6 indexed citations

10.

Canuso, Carla M., Bryan Dirks, Jennifer Carothers, Yiping Zhu, & Colette Kosik‐Gonzalez. (2008). 305 – A comparative analysis of paliperidone ER and quetiapine in patients with a recent, acute exacerbation of schizophrenia. Schizophrenia Research. 98. 158–159. 3 indexed citations

11.

Mahmoud, Ramy, Gahan Pandina, Ibrahim Turkoz, et al.. (2007). Risperidone for Treatment-Refractory Major Depressive Disorder. Annals of Internal Medicine. 147(9). 593–602. 98 indexed citations

12.

Rupnow, Marcia F.T., Andrew Greenspan, Georges M. Gharabawi, et al.. (2007). Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder. Current Medical Research and Opinion. 23(11). 2815–2822. 26 indexed citations

13.

Gharabawi, Georges M., Andrew Greenspan, Marcia F.T. Rupnow, et al.. (2006). Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial. BMC Psychiatry. 6(1). 45–45. 46 indexed citations

14.

Potkin, Steven G., Georges M. Gharabawi, Andrew Greenspan, et al.. (2006). A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Schizophrenia Research. 85(1-3). 254–265. 79 indexed citations

15.

Gharabawi, Georges M., Carla M. Canuso, Gahan Pandina, et al.. (2006). P.8.a.053 A double-blind placebo-controlled study of adjunctive risperidone for treatment-resistant major depressive disorder. European Neuropsychopharmacology. 16. S562–S562. 6 indexed citations

16.

Greenspan, Andrew, et al.. (2005). PMH47 USE AND COST OF POLYPHARMACY IN SCHIZOPHRENIA: DATA FROM A RANDOMIZED, DOUBLE-BLIND STUDY OF RISPERIDONE AND QUETIAPINE. Value in Health. 8(3). 399–399. 6 indexed citations

17.

Potkin, Steven G., Georges M. Gharabawi, Andrew Greenspan, et al.. (2005). Psychometric evaluation of the Readiness for Discharge Questionnaire. Schizophrenia Research. 80(2-3). 203–212. 21 indexed citations

18.

Ruetsch, Charles, et al.. (2005). PMH46 RELIABILITY AND VALIDITY OF THE READINESS FOR DISCHARGE QUESTIONNAIRE IN SCHIZOPHRENIA. Value in Health. 8(3). 398–399. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact